ReVision Optics, Inc. Closes Series E Preferred Stock Financing

Represented ReVision Optics, Inc. in closing and funding the final piece of its Series E Preferred Stock financing for $55 million. Investors in this round included prior investors Domain Associates and InterWest Partners, as well as Johnson & Johnson Development Corporation and RusnanoMedInvest.

In April, Revision Optics completed a $15 million funding round. ReVision Optics is a privately held corporation focused on developing unique optical solutions for the treatment of presbyopia.

Related Attorneys